Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study.

Eun-Jee OhSung Soo ParkKi Hyun ParkHyun Joo BaeSo Jeong YunGi June MinSung-Soo ParkSilvia ParkSung-Eun LeeByung-Sik ChoKi-Seong EomYoo-Jin KimSeok LeeHee-Je KimChang-Ki MinSeok-Goo ChoKyungja HanJong Wook Lee

Published in: Therapeutic advances in hematology (2021)

Clinical Research Information Service [Internet]; Osong (Chungcheongbuk-do), Korea, Centers for Disease Control and Prevention, Ministry of Health and Welfare (Republic of Korea); https://cris.nih.go.kr/cris/index.jsp; Feb, 16th 2016; KCT0001886 (KC15TISE0936).

Keyphrases

phase ii
health information
clinical trial
healthcare
mental health
open label
public health
single cell
cell therapy
social media
placebo controlled
phase iii
double blind
stem cells
randomized controlled trial
nk cells